🇺🇸 FDA
Pipeline program

Phase I Study of Plitidepsin Administered Intravenously as a Single Dose in Healthy Volunteers

HV-APL-A-001-24

Phase 1 other active

Quick answer

Phase I Study of Plitidepsin Administered Intravenously as a Single Dose in Healthy Volunteers for Virus diseases is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Virus diseases
Phase
Phase 1
Modality
other
Status
active

Clinical trials